- Abstract
- 10.1016/j.atherosclerosissup.2018.04.456
Efficacy of Lomitapide Across the Spectrum of Homozygous Familial Hypercholesterolemia
- Jun 01, 2018
- Atherosclerosis Supplements
- Robert A Hegele + 4 more +4
Publications from 2021 to 2026
Showing 3 of 3 papers
Efficacy of Lomitapide Across the Spectrum of Homozygous Familial Hypercholesterolemia
Long-term Liver Safety of Lomitapide in Patients with Homozygous Familial Hypercholesterolemia: Three-year Data from LOWER
Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo